Our Advisory Board provides us with the expertise, support and challenge required to maintain Biovault’s industry-leading position. 


Dr Hannah Hunter

Hannah is a consultant haematologist with a special interest in bone marrow transplantation and the management of acute leukaemia and multiple myeloma. 

Based at Derriford Hospital, Plymouth, a teaching hospital and large tertiary referral centre, Hannah’s role combines clinical and laboratory duties. Since 2006 Hannah has been one of four consultants managing a multidisciplinary team involved in the care of patients undergoing allogenic and autologous stem cell transplantation. This includes clinical and stem cell collection units (by aphaeresis and bone marrow harvesting) and a stem cell processing team. 

Hannah has been a medical consultant to Biovault since 2008 and our Medical Director since January 2009. 


Kate Sneddon

Kate studied Microbiology at Newcastle University, joining Glaxo Wellcome (now GlaxoSmithKline or GSK) upon completion of her degree. Prior to her role as CEO of Biovault Family and Biovault Technical, Kate held the roles of Operations Director and Technical Director. Whilst CEO, Kate was recognised in 2019 as an Inspirational Woman in STEMM, winning a Venus Award for her contribution to biotechnology. 

Having left Biovault in 2022, Kate has remained an active part of the Advisory Board as a statutory director.